CD8A and neoplasm: High-grade serous ovarian cancer (HGSOC) with BRCA-1/2 mutations has a higher density of CD3+ and CD8+ tumor-infiltrating lymphocytes (TILs) in comparison to homologous recombination proficient OC [7,24,25].